GNRH1 and breast cancer: They also state that GnRH agonists may be offered to breast cancer patients to reduce the risk of premature ovarian insufficiency [24] but should not be used in place of other fertility preservation alternatives [15] and that more studies are required to establish the efficacy of this treatment and to determine which patients are the best candidates for its use.